My Companies
Notification
Account
Log Out
Login
Noumed renewed a three-year OTC supply agreement with a leading Australian pharmacy chain worth AUD30 million (approximately ₹204 crore), including new product development and line extensions. Combined Australian OTC contracted supply reaches AUD232 million (approximately ₹1,506 crore); current third-party sourcing is expected to shift toward higher-margin in-house manufacturing as Adelaide and Indian capacity expand.
Sai Parenterals Renews ₹204 Crore Australian OTC Supply Agreement
Sai Parenterals Redirects ₹83.83 Crore IPO Proceeds To Saicriti Acquisition
Sai Parenterals Approves ₹101.86 Crore IPO Proceeds Shift Into Two Pharma Acquisitions
Sai Parenterals Subsidiary Bags AUD 202 Million OTC Supply Deal